Halloween Autism Charity Blitz, OLFC to Donate 20% of All Autism Balm Sales to Autism Charity of Buyer's Choice
October 31 2013 - 6:00AM
Marketwired
Halloween Autism Charity Blitz, OLFC to Donate 20% of All Autism
Balm Sales to Autism Charity of Buyer's Choice
In Its Latest Effort to Help Families and Individuals With
Autism, OLFC Will Donate 20% of Each Autism Balm Sale to the Autism
Charity Determined by the Buyer in the Notes Field of Each
Amazon.com Purchase
PHILADELPHIA, PA--(Marketwired - Oct 31, 2013) - Olfactory
Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Balm™,
is pleased to announce today that they are donating 20% of all NOXO
Autism Balm™ sales to the charity of the buyers choice over the
next 24 hours. All a buyer needs to do is enter the name of their
preferred Autism Charity in the notes field on their Amazon.com
order and the charity indicated will receive a donation of 20% of
that sale.
OLFC is dedicated to helping as many people as possible that may
suffer from the effects of behavioral issues related to
sensitivities and overstimulation in children and adults with
Autism. NOXO stops the frequency of behavioral issues that trouble
individuals with sensitivities by stopping irritant odors and
inducing a natural calming effect. Providing protection and relief
to the overstimulated person.
Our NOXO brand is currently working with multiple Autism
Charities to provide quality information, products and services in
order to better assist those affected by Autism. However, on Oct
31, 2013 any Autism Charity can get a donation determined by the
purchaser of the NOXO Autism Balm™.
You can get more information on NOXO Autism balm™ at
www.noxoinfo.com/autism.html
or on Amazon.com search term: NOXO Autism
About Olfactory Biosciences Corp.
(http://www.noxoinfo.com/investor)
Olfactory Biosciences Corp.'s NOXO division is focused to
develop a variety of products targeting Olfactory Receptors for the
desired effect. These alternative medicine wellness products may
modify behavior or provide relief to common behavior challenges
such as anxiety, smoking or weight control, as examples.
FORWARD-LOOKING STATEMENTS
"Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995: Statements by the Company, statements regarding
the NOXO product line, optimism related to the business, expanding
ales and other statements in this press release are forward-looking
statements within the meaning of the Securities Litigation Reform
Act of 1995. Such statements are based on current expectations,
estimates and projections about the Company's business. Words such
as expects, anticipates, intends, plans, believes, sees, estimates
and variations of such words and similar expressions are intended
to identify such forward-looking statements. These statements are
not guarantees of future performance and involve certain risks and
uncertainties that are difficult to predict. Actual results could
vary materially from the description contained herein due to many
factors including continued market acceptance of the Company's
products or the need to raise additional capital. In addition,
actual results could vary materially based on changes or slower
growth in the indoor garden market; the potential inability to
realize expected benefits and synergies; domestic and international
business and economic conditions; changes in customer demand or
ordering patterns; changes in the competitive environment including
pricing pressures or technological changes; technological advances;
shortages of manufacturing capacity; future production variables
impacting excess inventory and other risk factors listed from time
to time in the Company's Securities and Exchange Commission (SEC)
filings under "risk factors" and elsewhere. The forward-looking
statements contained in this press release speak only as of the
date on which they are made, and the Company does not undertake any
obligation to update any forward-looking statement to reflect
events or circumstances after the date of this press release.
Richard Stevenson President Olfactory Biosciences Corp. 333 E.
Lancaster Ave. Suite 317 Wynnewood, PA 19096, USA Phone:
484-278-1626
(USOTC:OLFC)
Historical Stock Chart
From May 2024 to Jun 2024
(USOTC:OLFC)
Historical Stock Chart
From Jun 2023 to Jun 2024